Causal inference in a clinical trial: A comparative example

Controlled Clinical Trials

Volumn 20, Issue 4, 1999, Pages 309-318

  Heitjan, Daniel F ^a  

^a Divsion of Biostatistics Joseph L Mailman Sch Pub H ^*  (United States)

Author keywords

Intention to treat analysis; Noncompliance; Nonignorable model

Indexed keywords

AZATHIOPRINE; METHYLPREDNISOLONE; PLACEBO;

ARTICLE; BIOSTATISTICS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PATIENT COMPLIANCE; PROBABILITY; RANDOMIZATION; STATISTICAL CONCEPTS; STATISTICAL MODEL;

EID: 0032988557     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(99)00012-4     Document Type: Article

References (11)

1. Heitjan DF. Ignorability and bias in clinical trials. Stat Med (in press) 1999.
2. Urquhart J., De Klerk E. Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens. Stat Med. 17:1998;251-267.
3. Diggle P., Kenward M.G. Informative drop-out in longitudinal data analysis (with discussion). Appl Stat. 43:1994;49-94.
4. Sommer A., Zeger S.L. On estimating efficacy from clinical trials. Stat Med. 10:1991;45-52. Correction 1994;13:1897.
5. Sheiner L.B., Rubin D.B. Intention-to-treat analysis and the goals of clinical trials. Clin Pharm Ther. 57:1995;6-15.
6. Angrist J.D., Imbens G.W., Rubin D.B. Identification of causal effects using instrumental variables (with discussion). J Am Stat Assoc. 91:1996;444-472.
7. Imbens G.W., Rubin D.B. Bayesian inference for causal effects in randomized experiments with noncompliance. Ann Statist. 25:1997;305-327.
8. Ellison G.W., Myers L.W., Mickey M.R.et al. A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis. Neurology. 39:1989;1018-1026.
9. Heitjan D.F. Nonlinear modeling of serial immunologic data. A case study J Am Stat Assoc. 86:1991;891-898.
10. Critchley F., Ford I., Rijal O. Interval estimation based on the profile likelihood. Strong Lagrangian theory with applications to discrimination Biometrika. 75:1988;21-28.
11. Efron B., Feldman D. Compliance as an explanatory variable in clinical trials (with discussion). J Am Stat Assoc. 86:1991;9-26.